Sally L Hampton

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Diffusion Weighted Imaging

Particulate Matter

Anti Inflammatory

Top Venues

ACS medicinal chemistry letters

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew Allison, Rebecca L Davie, Adrian J Mogg, Sally L Hampton, Jonas Emsley, Michael J Stocks
Discovery of α-Amidobenzylboronates as Highly Potent Covalent Inhibitors of Plasma Kallikrein. ACS medicinal chemistry letters 15 (4) (2024)
Matthew Allison, Rebecca L Davie, Adrian J Mogg, Sally L Hampton, Jonas Emsley, Michael J Stocks
Discovery of α-Amidobenzylboronates as Highly Potent Covalent Inhibitors of Plasma Kallikrein. ACS medicinal chemistry letters 15 (4) (2024)
Matthew Allison, Rebecca L Davie, Adrian J Mogg, Sally L Hampton, Jonas Emsley, Michael J Stocks
Discovery of α-Amidobenzylboronates as Highly Potent Covalent Inhibitors of Plasma Kallikrein. ACS medicinal chemistry letters 15 (4) (2024)
Edward J Duckworth, Nivetha Murugesan, Lily Li, Louise J Rushbrooke, Daniel K Lee, Gian Marco De Donatis, Andreas Maetzel, Christopher M Yea, Sally L Hampton, Edward P Feener
Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 52 (9) (2022)